De fleste af patienterne fik forsøgsmedicinen i tilgift til konventionel behandling, inklusive trombocytfunktionshæmmende midler, lipidsænkende midler og betablokkere. ###>Most of the patients received the study medication on top of conventional therapy including platelet inhibitors, lipid lowering agents and beta-blockers.